StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) bonds

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)

Close on Nov 18, 2026Market cap $154.73MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

GT Biopharma reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in GT Biopharma's 10-K for the period ended Dec 31, 2022

IssueAmount issuedCarrying value
Notes Payable Issued For Cash
Convertible at $3 a share
–$24.10M
Notes Payable Issued For Consulting Agreement
Convertible at $3 a share
$33.30M$38.80M
Notes Payable Issued For Forbearance Agreements
Convertible at $3 a share
$13.20M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?